The ability to detect single protein molecules1,2 in blood could accelerate the discovery and use of more sensitive diagnostic biomarkers. To detect low-abundance proteins in blood, we captured them on microscopic beads decorated with specific antibodies and then labeled the immunocomplexes (one or zero labeled target protein molecules per bead) with an enzymatic reporter capable of generating a fluorescent product. After isolating the beads in 50-fl reaction chambers designed to hold only a single bead, we used fluorescence imaging to detect single protein molecules. Our single-molecule enzyme-linked immunosorbent assay (digital ELISA) approach detected as few as ∼10–20 enzyme-labeled complexes in 100 μl of sample (∼10−19 M) and routinely allowed detection of clinically relevant proteins in serum at concentrations (<10−15 M) much lower than conventional ELISA3,4,5. Digital ELISA detected prostate-specific antigen (PSA) in sera from patients who had undergone radical prostatectomy at concentrations as low as 14 fg/ml (0.4 fM).
Subscribe to Journal
Get full journal access for 1 year
only $8.25 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Tessler, L.A., Reifenberger, J.G. & Mitra, R.D. Protein quantification in complex mixtures by solid phase single-molecule counting. Anal. Chem. 81, 7141–7148 (2009).
Todd, J. et al. Ultrasensitive flow-based immunoassays using single-molecule counting. Clin. Chem. 53, 1990–1995 (2007).
Gosling, J.P.A. Decade of development in immunoassay methodology. Clin. Chem. 36, 1408–1427 (1990).
Wild, D. The Immunoassay Handbook 3rd Edn. (Elsevier, 2005).
Zhang, H.Q., Zhao, Q., Li, X.F. & Le, X.C. Ultrasensitive assays for proteins. Analyst (Lond.) 132, 724–737 (2007).
Giljohann, D.A. & Mirkin, C.A. Drivers of biodiagnostic development. Nature 462, 461–464 (2009).
Srinivas, P.R., Kramer, B.S. & Srivastava, S. Trends in biomarker research for cancer detection. Lancet Oncol. 2, 698–704 (2001).
Galasko, D. Biomarkers for Alzheimer's disease—clinical needs and application. J. Alzheimers Dis. 8, 339–346 (2005).
de Jong, D., Kremer, B.P.H., Olde Rikkert, M.G.M. & Verbeek, M.M. Current state and future directions of neurochemical biomarkers for Alzheimer's disease. Clin. Chem. Lab. Med. 45, 1421–1434 (2007).
Barletta, J.M., Edelman, D.C. & Constantine, N.T. Lowering the detection limits of HIV-1 viral load using real-time immuno-PCR for HIV-1 p24 antigen. Am. J. Clin. Pathol. 122, 20–27 (2004).
Adler, M., Wacker, R. & Niemeyer, C.M. Sensitivity by combination: immuno-PCR and related technologies. Analyst (Lond.) 133, 702–718 (2008).
Nam, J.M., Thaxton, C.S. & Mirkin, C.A. Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins. Science 301, 1884–1886 (2003).
Armani, A.M., Kulkarni, R.P., Fraser, S.E., Flagan, R.C. & Vahala, K.J. Label-free, single-molecule detection with optical microcavities. Science 317, 783–787 (2007).
Cui, Y., Wei, Q.Q., Park, H.K. & Lieber, C.M. Nanowire nanosensors for highly sensitive and selective detection of biological and chemical species. Science 293, 1289–1292 (2001).
Gaster, R.S. et al. Matrix-insensitive protein assays push the limits of biosensors in medicine. Nat. Med. 15, 1327–1332 (2009).
Fan, R. et al. Integrated barcode chips for rapid, multiplexed analysis of proteins in microliter quantities of blood. Nat. Biotechnol. 26, 1373–1378 (2008).
Thaxton, C.S. et al. Nanoparticle-based bio-barcode assay redefines “undetectable” PSA and biochemical recurrence after radical prostatectomy. Proc. Natl. Acad. Sci. USA 106, 18437–18442 (2009).
Bao, Y.P. et al. Detection of protein analytes via nanoparticle-based bio bar code technology. Anal. Chem. 78, 2055–2059 (2006).
Anderson, N.L. & Anderson, N.G. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 1, 845–867 (2002).
Gorris, H.H., Rissin, D.M. & Walt, D.R. Stochastic inhibitor release and binding from single-enzyme molecules. Proc. Natl. Acad. Sci. USA 104, 17680–17685 (2007).
Rissin, D.M., Gorris, H.H. & Walt, D.R. Distinct and long-lived activity states of single enzyme molecules. J. Am. Chem. Soc. 130, 5349–5353 (2008).
Rissin, D.M. & Walt, D.R. Digital readout of target binding with attomole detection limits via enzyme amplification in femtoliter arrays. J. Am. Chem. Soc. 128, 6286–6287 (2006).
Rissin, D.M. & Walt, D.R. Digital concentration readout of single enzyme molecules using femtoliter arrays and Poisson statistics. Nano Lett. 6, 520–523 (2006).
Tan, W. & Yeung, E.S. Monitoring the reactions of single enzyme molecules and single metal ions. Anal. Chem. 69, 4242–4248 (1997).
Rissin, D.M. & Walt, D.R. Duplexed sandwich immunoassays on a fiber-optic microarray. Anal. Chim. Acta 564, 34–39 (2006).
Ferguson, R., Yu, H., Kalyvas, M., Zammit, S. & Diamandis, E. Ultrasensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the Immulite immunochemiluminescent third-generation assay: potential applications in prostate and breast cancers. Clin. Chem. 42, 675–684 (1996).
Jackson, T.M. & Ekins, R.P. Theoretical limitations on immunoassay sensitivity. Current practice and potential advantages of fluorescent Eu3+ chelates as non-radioisotopic tracers. J. Immunol. Methods 87, 13–20 (1986).
Bock, J.L. & Klee, G.G. How sensitive is a prostate-specific antigen measurement? How sensitive does it need to be? Arch. Pathol. Lab. Med. 128, 341–343 (2004).
Trock, B.J. et al. Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy. Jama-Journal of the American Medical Association 299, 2760–2769 (2008).
Pantano, P. & Walt, D.R. Ordered nanowell arrays. Chem. Mater. 8, 2832–2835 (1996).
The project described was supported by Award Number R43CA133987 from the National Cancer Institute.
All authors are employees or advisors of Quanterix Corporation who have a minority ownership or ownership option position in the company.
About this article
Cite this article
Rissin, D., Kan, C., Campbell, T. et al. Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat Biotechnol 28, 595–599 (2010). https://doi.org/10.1038/nbt.1641
Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer’s disease pathology and clinical disease progression
Alzheimer's Research & Therapy (2021)
A cross-sectional study in healthy elderly subjects aimed at development of an algorithm to increase identification of Alzheimer pathology for the purpose of clinical trial participation
Alzheimer's Research & Therapy (2021)
Ultrasensitive assays for detection of plasma tau and phosphorylated tau 181 in Alzheimer’s disease: a systematic review and meta-analysis
Translational Neurodegeneration (2021)
Targeting autonomic flexibility to enhance cognitive training outcomes in older adults with mild cognitive impairment: study protocol for a randomized controlled trial
Nature Methods (2021)